Granted Patent
B2
US 11,613,517 · App. 16/971,171 · Granted Mar 28, 2023
Amide prodrugs of small molecule nuclear receptor modulators
Assignee:
OREGON HEALTH & SCIENCE UNIVERSITY
View Patent ↗
Loading inventors, assignments & file history…
Abstract
Provided herein are novel amide prodrug forms of pharmaceutically active agents useful for central nervous system disorders.
Claims (4)
1. A compound:
or a pharmaceutically acceptable salt thereof.
2. A pharmaceutical composition comprising a pharmaceutically effective amount of the compound of claim 1 , or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier or excipient.
3. A method of treating a neurodegenerative disorder in a subject in need thereof comprising administering to the subject a pharmaceutically effective amount of the compound of claim 1 , or a pharmaceutically acceptable salt thereof.
Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Sep 22, 2020
From: SCANLAN, THOMAS S.; FERRARA, SKYLAR J.
To: OREGON HEALTH & SCIENCE UNIVERSITY
Reel/Frame 053842/0767 →
Continuity (2)
Provisional Application
62637884
· Mar 2, 2018
Cited By (4)